The AAMC joined a Nov. 2 letter (PDF) signed by over 500 national, state, and local organizations in support of the 340B Rebate Model Delay Act (H.R. 10770). Led by Reps. Rob Bresnahan (R-Pa.), Debbie Dingell (D-Mich.), Tracey Mann (R-Kan.), and Lois Frankel (D-Fla.), the legislation would delay implementation of the Health Resources and Services Administration 340B Rebate Model Pilot Program for two years while Congress considers comprehensive bipartisan 340B reform proposals, such as the House SECURE 340B Act and the Senate SUSTAIN 340B Act [refer to Washington Highlights, July 10; Oct. 23].
In the letter, the groups outline their opposition to the pilot program, which would restructure 340B pricing from an upfront discount to a back-end rebate for certain drugs. The signatories emphasize that the pilot would disrupt over thirty years of program precedent, while "shift[ing] all financial and operational risk onto safety-net providers, the very same groups the program was created to benefit." The letter urges lawmakers to address this issue before the pilot program takes effect on Jan. 1, 2027, by including H.R. 10770 in a potential year-end legislative package.
- Washington Highlights